{"id":349194,"date":"2024-10-20T00:35:21","date_gmt":"2024-10-20T00:35:21","guid":{"rendered":"https:\/\/pdfstandards.shop\/product\/uncategorized\/bs-en-iso-116162012\/"},"modified":"2024-10-26T00:14:52","modified_gmt":"2024-10-26T00:14:52","slug":"bs-en-iso-116162012","status":"publish","type":"product","link":"https:\/\/pdfstandards.shop\/product\/publishers\/bsi\/bs-en-iso-116162012\/","title":{"rendered":"BS EN ISO 11616:2012"},"content":{"rendered":"
PDF Pages<\/th>\n | PDF Title<\/th>\n<\/tr>\n | ||||||
---|---|---|---|---|---|---|---|
6<\/td>\n | Foreword <\/td>\n<\/tr>\n | ||||||
7<\/td>\n | Introduction <\/td>\n<\/tr>\n | ||||||
9<\/td>\n | 1\tScope 2\tNormative references <\/td>\n<\/tr>\n | ||||||
10<\/td>\n | 3\tTerms, definitions and abbreviations 3.1\tTerms and definitions <\/td>\n<\/tr>\n | ||||||
15<\/td>\n | 3.2\tAbbreviations <\/td>\n<\/tr>\n | ||||||
16<\/td>\n | 4\tRequirements 4.1\tElements required for the unique identification of pharmaceutical products <\/td>\n<\/tr>\n | ||||||
17<\/td>\n | 4.2\tExchange of pharmaceutical product information 5\tIdentifying characteristics for the identification of pharmaceutical products 5.1\tPharmaceutical product identification strata and levels <\/td>\n<\/tr>\n | ||||||
19<\/td>\n | 5.2\tCardinality <\/td>\n<\/tr>\n | ||||||
20<\/td>\n | 5.3\tRepresentation of strength concentration 5.4\tPharmaceutical product identifier (PhPID) <\/td>\n<\/tr>\n | ||||||
21<\/td>\n | 5.5\tPharmaceutical product substance stratum elements (PhPID_SUB_Lx) <\/td>\n<\/tr>\n | ||||||
23<\/td>\n | 5.6\tPharmaceutical Product Specified Substance Stratum Elements (PhPID_SpSUB_Lx) <\/td>\n<\/tr>\n | ||||||
25<\/td>\n | 5.7\tIdentifying characteristics to express strength <\/td>\n<\/tr>\n | ||||||
27<\/td>\n | 6\tRelationship between MPID and PhPID 6.1\tConcepts required for the unique identification of a medicinal product and the association with PhPIDs <\/td>\n<\/tr>\n | ||||||
29<\/td>\n | 6.2\tPharmaceutical product identification criteria <\/td>\n<\/tr>\n | ||||||
31<\/td>\n | 7\tRelationship between IMPID and PhPID <\/td>\n<\/tr>\n | ||||||
33<\/td>\n | 8\tConceptual model <\/td>\n<\/tr>\n | ||||||
35<\/td>\n | Annex\u00a0A \n(informative)<\/p>\n Examples <\/td>\n<\/tr>\n | ||||||
43<\/td>\n | Annex\u00a0B \n(informative)<\/p>\n Tabled examples <\/td>\n<\/tr>\n | ||||||
46<\/td>\n | Bibliography <\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":" Health informatics. Identification of medicinal products. Data elements and structures for the unique identification and exchange of regulated pharmaceutical product information<\/b><\/p>\n |